Followers | 88 |
Posts | 8196 |
Boards Moderated | 0 |
Alias Born | 06/17/2013 |
![](https://investorshub.advfn.com/uicon/404071.png?cb=1506674193)
Monday, October 26, 2015 10:18:23 AM
From Dr. Mahant’s CV at http://therapeuticsolutionsint.com/CV/Vijay-Mahant_CV.pdf
Partial list of Publications/Abstracts :
Over 17 articles published with the most relevant listed below:
· Flow-injection analysis with chemiluminescence detection in the determination of fluoroscein and fluorescamine-labeled species. Mahant V.K et al, Anal Chem. Acta, 145: 203-206 1983.
· The development of an ultra-sensitive two-site chemiluminometric assay for thyroid stimulating hormone. Vijay K. Mahant and Ashok Patel, Journal of Clinical Immunoassay, 11 (1), 1988 (abstract).
· A two-site chemiluminescence immunoassay for human prolactin. Vijay K. Mahant et al, Journal of Clinical Immunoassay, 11 (1), 1988 (abstract).
· Luminescent Labels, A review of properties and chemistry. F. McCapra, V.K. Mahant, et al, Journal of Bioluminescence and Chemiluminescence, 2 (4) 1988 (abstract).
· A sensitive enzyme-mediated chemiluminescence immunoassay for intact human parathyroid hormone. V.K. Mahant et al, Endocrine Society, 1990 (abstract).
· Development of enzyme-mediated chemiluminescence immunoassay for thyroid stimulating hormone. K. Nozawa-Ung, V.K. Mahant, et al, Journal of Clinical Immunoassay, 1990 (abstract).
· Development of enzyme-mediated chemiluminescence immunoassays for human luteinizing hormone and follicle stimulating hormone. G. Odstrchel et al, Bioluminescence and Chemiluminescence current status, edited by P. Stanley and L. Kricka, John Wiley & Sons, 1991 (p127).
· A sensitive enzyme-mediated chemiluminescence immunoassay for human chorionic gonadotropin. Vijay K. Mahant et al, Clinical Chemistry, 36 (6), 1990 (abstract).
· Development of a sensitive and specific immunoradiometric assay for human luteinizing hormone based on a modified avidin and biotin. Vijay K. Mahant et al, Journal of Clinical Immunoassay, 14 (1), 1991 (abstract).
· Development of immunoradimetric assays for luteinizing and follicle stimulating hormone using avidin-coated paramagnetic particles. V.K. Mahant et al, Journal of Clinical Immunoassay, (1992) (abstract).
· Development of an immunoradiometric assay for human prolactin using avidin-coated paramagnetic particles. V.K. Mahant et al, Clinical Chemistry, 38 (6), 1992 (abstract).
· Development of a sensitive immunoradiometric assay for thyroid stimulating hormone using avidin-coated paramagnetic particles. Vijay K Mahant et al, Journal of Clinical Immunoassay, 16 (1), 1993 (abstract).
· Development of a sensitive enzyme immunoassay for neonatal thyroid stimulating hormone. Vijay K Mahant et al, Clinical Chemistry, 39 (6), 1993 (abstract).
Recent TSOI News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:44:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 06:14:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 07:42:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 07:38:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:44:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:39:55 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/31/2024 08:51:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 04:47:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 12:46:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 12:44:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/30/2024 06:46:26 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 04:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 10:03:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:15:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:12:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:16:15 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/08/2024 05:15:25 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:34:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:42:55 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/17/2024 11:15:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/04/2024 09:03:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 07:44:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:39:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:17:29 PM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM